STA
CVS icon

Summit Trail Advisors’s CVS Health CVS Stock Holding History

Summit Trail Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Sell
50,980
-2,394
-4% -$214K 0.07% 175
2026
Q1 		$3.83M Buy
53,374
+10,218
+24% +$787K 0.05% 226
2025
Q4 		$3.42M Sell
43,156
-6,580
-13% -$519K 0.06% 195
2025
Q3 		$3.75M Buy
49,736
+11,882
+31% +$814K 0.05% 190
2025
Q2 		$2.61M Buy
+37,854
New +$2.48M 0.04% 214
2024
Q4 		– Sell
-8,579
Closed -$539K – 479
2024
Q3 		$539K Sell
8,579
-5,703
-40% -$333K 0.01% 386
2024
Q2 		$843K Buy
14,282
+3,564
+33% +$223K 0.02% 266
2024
Q1 		$855K Buy
10,718
+2,332
+28% +$178K 0.02% 239
2023
Q4 		$662K Sell
8,386
-127
-1% -$9.04K 0.02% 234
2023
Q3 		$594K Sell
8,513
-124
-1% -$8.79K 0.02% 242
2023
Q2 		$597K Buy
8,637
+3,342
+63% +$238K 0.02% 233
2023
Q1 		$393K Buy
5,295
+1,239
+31% +$104K 0.02% 261
2022
Q4 		$378K Sell
4,056
-915
-18% -$88.3K 0.02% 233
2022
Q3 		$474K Buy
4,971
+1,143
+30% +$113K 0.03% 188
2022
Q2 		$355K Buy
3,828
+560
+17% +$54.7K 0.02% 241
2022
Q1 		$331K Sell
3,268
-202
-6% -$21.2K 0.03% 232
2021
Q4 		$358K Sell
3,470
-700
-17% -$64.7K 0.02% 204
2021
Q3 		$354K Buy
4,170
+454
+12% +$38K 0.03% 190
2021
Q2 		$310K Buy
3,716
+43
+1% +$3.52K 0.03% 171
2021
Q1 		$276K Buy
+3,673
New +$268K 0.03% 161
2018
Q1 		– Sell
-2,451
Closed -$194K – 726
2017
Q4 		$194K Buy
+2,451
New +$178K 0.02% 432

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Summit Trail Advisors's CVS Position: Q2 2026 in Review

Summit Trail Advisors reduced its CVS Health (CVS) stake by 4.5% in Q2 2026, selling an estimated $214K and leaving 50,980 shares worth $5.27M. The position accounts for 0.07% of the portfolio, ranked #175.

Summit Trail Advisors first reported a position in CVS in Q4 2017 and has held it in 21 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Summit Trail Advisors held 50,980 shares of CVS Health worth $5.27M as of Q2 2026.
  • Summit Trail Advisors sold 2,394 CVS Health shares in Q2 2026, an estimated $214K.
  • CVS Health made up 0.07% of Summit Trail Advisors's portfolio in Q2 2026, its #175 holding.
  • Summit Trail Advisors first reported a position in CVS Health in Q4 2017 and has held it in 21 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.